Search

Your search keyword '"Nieminen, Sakari"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Nieminen, Sakari" Remove constraint Author: "Nieminen, Sakari"
25 results on '"Nieminen, Sakari"'

Search Results

1. Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

2. Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

4. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

5. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

6. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

12. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

13. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

14. Fighting Misperceptions and Doubting Journalists' Objectivity: A Review of Fact-checking Literature.

15. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

16. Faktan tarkistajat harhateillä.

25. The quality and characteristics of clinical drug study notifications reviewed by the regulatory agency in Finland

Catalog

Books, media, physical & digital resources